Ontology highlight
ABSTRACT:
SUBMITTER: Geijsen AJMR
PROVIDER: S-EPMC7583160 | biostudies-literature | 2020 Oct
REPOSITORIES: biostudies-literature
Geijsen Anne J M R AJMR Ulvik Arve A Gigic Biljana B Kok Dieuwertje E DE van Duijnhoven Fränzel J B FJB Holowatyj Andreana N AN Brezina Stefanie S van Roekel Eline H EH Baierl Andreas A Bergmann Michael M MM Böhm Jürgen J Bours Martijn J L MJL Brenner Hermann H Breukink Stéphanie O SO Bronner Mary P MP Chang-Claude Jenny J de Wilt Johannes H W JHW Grady William M WM Grünberger Thomas T Gumpenberger Tanja T Herpel Esther E Hoffmeister Michael M Huang Lyen C LC Jedrzkiewicz Jolanta D JD Keulen Eric T P ETP Kiblawi Rama R Kölsch Torsten T Koole Janna L JL Kosma Katharina K Kouwenhoven Ewout A EA Kruyt Flip M FM Kvalheim Gry G Li Christopher I CI Lin Tengda T Ose Jennifer J Pickron T Bartley TB Scaife Courtney L CL Schirmacher Peter P Schneider Martin A MA Schrotz-King Petra P Singer Marie C MC Swanson Eric R ER van Duijvendijk Peter P van Halteren Henk K HK van Zutphen Moniek M Vickers Kathy K Vogelaar F Jeroen FJ Wesselink Evertine E Habermann Nina N Ulrich Alexis B AB Ueland Per M PM Weijenberg Matty P MP Gsur Andrea A Ulrich Cornelia M CM Kampman Ellen E
JNCI cancer spectrum 20200707 5
<h4>Background</h4>Folates, including folic acid, may play a dual role in colorectal cancer development. Folate is suggested to be protective in early carcinogenesis but could accelerate growth of premalignant lesions or micrometastases. Whether circulating concentrations of folate and folic acid, measured around time of diagnosis, are associated with recurrence and survival in colorectal cancer patients is largely unknown.<h4>Methods</h4>Circulating concentrations of folate, folic acid, and fol ...[more]